Calm Magnesium Capsules

Arrae Calm Magnesium scores 10/25 due to critical formulation weaknesses that undermine efficacy claims. The magnesium dose is only 63 mg as magnesium bisglycinate —well below clinically meaningful levels. ConsumerLab testing shows magnesium supplements typically range from 77 mg to 566 mg daily, placing this product at the bottom of the therapeutic range. While magnesium bisglycinate is a bioavailable form, the dose is insufficient for the anxiety and nervous system support claimed. The remaining 950 mg is a proprietary blend of inositol, L-theanine, and passionflower extract with undisclosed individual amounts, preventing assessment of whether these actives are dosed at evidence-supported levels. No third-party certifications (NSF, Informed Sport, USP) are disclosed. The product relies on marketing claims rather than transparent formulation or independent verification of efficacy.

Arrae Calm Magnesium uses a preferred magnesium form (Bisglycinate), which is a positive signal for bioavailability and ingredient quality. However, the formulation has significant integrity gaps. The product contains a 950 mg proprietary blend that obscures individual ingredient amounts for Inositol, L-Theanine, and Organic Passionflower 10:1 Extract, preventing assessment of whether doses are appropriate or whether fillers are present. No third-party testing disclosures (such as ConsumerLab testing or heavy-metal screening) are evident in the source corpus, which is a notable gap given that magnesium supplements have documented contamination risks. No certifications (NSF, BSCG, or Clean Label Project) are claimed or disclosed. While the ingredient list itself appears free of artificial sweeteners or obvious low-grade fillers, the lack of sourcing transparency, absence of contaminant testing disclosure, and proprietary blend opacity prevent a higher score. The product lands in the "mixed" band: the magnesium form is thoughtfully chosen, but overall transparency and verification are insufficient.

Arrae discloses full individual ingredient amounts for the magnesium component (63 mg) and a proprietary blend total (950 mg), but hides the individual dosages of Inositol, L-Theanine, and Passionflower Extract within that blend. The brand claims third-party batch testing including HPLC identity testing, heavy metal analysis, and microbiological testing, and states ingredients are "clinically-studied" with "gold-standard randomized, double-blind, placebo-controlled studies" backing them. However, no NSF Certified for Sport, Informed Sport, USP, or other credible third-party certification registry entry was found in the source corpus. The brand is DTC-positioned with strong influencer and community marketing, and no FDA/FTC enforcement history was found. Manufacturing location is not disclosed in the retrieved sources. The proprietary blend opacity and absence of independent third-party certification (NSF/Informed Sport/USP) prevent a higher score, despite the claimed third-party testing and clean regulatory record. This places the brand in the solid lower-mixed range: real compliance infrastructure (batch testing, ingredient sourcing claims) but without the independent formula verification that would lift it into the strong band.

Arrae Calm is priced as "slightly expensive in comparison to some other similar supplements", but the retrieved sources provide no specific pricing data to calculate $/serving or compare directly against certified peers. The product contains 63 mg magnesium bisglycinate plus a 950 mg proprietary blend [user-provided], with no third-party certifications disclosed [user-provided]. The proprietary blend opacity prevents verification that the L-theanine, inositol, and passionflower doses are clinically meaningful at this price point. While the ingredient selection (magnesium bisglycinate, L-theanine, inositol, passionflower) is evidence-based, the lack of dose transparency, absence of third-party testing or NSF/Informed Sport certification, and acknowledged premium pricing relative to alternatives suggest marketing markup is a significant cost driver. Without pricing data or quality certifications to justify the premium, this product appears to occupy a middle ground: better formulation than commodity stress supplements, but lacking the quality signals (independent certification, full dose disclosure, third-party testing) that would justify a premium price tier.

Arrae Calm shows mixed customer sentiment with meaningful polarization. On the positive side, Amazon reviews include several 5-star verified purchases praising the product's calming effects and ease of use. However, the broader Arrae brand picture reveals significant friction: Thingtesting's aggregated review data (3.5/5 stars, 55% would recommend) explicitly flags Arrae Calm as "ineffective", and independent editorial review notes the product "may only provide temporary relief to anxiety and sleep disorders". Amazon reviews themselves show polarization: multiple 4-star reviews describe effects as "mildly calming" or "subtle," while 2-star reviews report "no appreciable effect" and note the product is "expensive". Critically, Thingtesting's summary identifies "severe customer-service issues including unresponsive refunds and blocking on social media" across the Arrae brand, which is a material friction point. The community evidence is limited (no large social following data retrieved), and efficacy complaints dominate the independent signal. This places Arrae Calm in the mixed band: real positive sentiment exists, but complaint themes (ineffectiveness, high price, service failures) are substantial enough to prevent a higher score.